Hot Features
Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Oculis establishes its US headquarters in Boston, MA, a world-renowned biotech hub, to support its continued expansion following OCS listing into NASDAQ Oculis’s finance and development team...
ZUG, Switzerland and BOSTON, April 05, 2023 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS) (“Oculis”), a global biopharmaceutical company purposefully driven to save sight and improve eye...
ZUG, Switzerland and BOSTON, April 04, 2023 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS) (“Oculis”), a global biopharmaceutical company purposefully driven to save sight and improve eye...
ZUG, Switzerland, and BOSTON, March 22, 2023 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS) (“Oculis”), a global biopharmaceutical company purposefully driven to save sight and improve eye...
Completed enrollment in Phase 3 OPTIMIZE trial brings OCS-01 one step further on the regulatory path to approval.If approved, OCS-01 has the potential to become the first once-daily, topical...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.37 | -1.62852112676 | 22.72 | 22.75 | 21.87 | 68620 | 22.27486701 | CS |
| 4 | 5.03 | 29.0415704388 | 17.32 | 23.08 | 17.31 | 131863 | 21.06484451 | CS |
| 12 | 5.53 | 32.8775267539 | 16.82 | 23.08 | 14 | 66661 | 19.1272236 | CS |
| 26 | 10.85 | 94.347826087 | 11.5 | 23.08 | 10.79 | 52456 | 16.96963921 | CS |
| 52 | 8.85 | 65.5555555556 | 13.5 | 23.08 | 10.55 | 40431 | 15.24010215 | CS |
| 156 | 11.4 | 104.109589041 | 10.95 | 23.08 | 6.26 | 33126 | 13.77054502 | CS |
| 260 | 11.4 | 104.109589041 | 10.95 | 23.08 | 6.26 | 33126 | 13.77054502 | CS |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
